Literature DB >> 32184026

Body composition during outpatient treatment of severe acute malnutrition: Results from a randomised trial testing different doses of ready-to-use therapeutic foods.

Suvi T Kangas1, Pernille Kaestel2, Cécile Salpéteur3, Victor Nikièma4, Leisel Talley5, André Briend6, Christian Ritz2, Henrik Friis2, Jonathan C Wells7.   

Abstract

BACKGROUND & AIMS: Treatment of children with uncomplicated severe acute malnutrition (SAM) is based on ready-to-use therapeutic foods (RUTF) prescribed based on body weight and administered at home. Treatment performance is typically monitored through weight gain. We previously reported that a reduced dose of RUTF resulted in weight gain velocity similar to standard dose. Here we investigate the change in body composition of children treated for SAM and compare it to community controls, and describe the effect of a reduced RUTF dose on body composition at recovery.
METHODS: Body composition was measured via bio-electrical impedance analysis at admission and recovery among a sub-group of children with SAM participating in a clinical trial and receiving a reduced or a standard dose of RUTF. Non-malnourished children were measured to represent community controls. Linear mixed regression models were fitted.
RESULTS: We obtained body composition data from 452 children at admission, 259 at recovery and 97 community controls. During SAM treatment the average weight increased by 1.20 kg of which 0.55 kg (45%) was fat-free mass (FFM) and 0.67 kg (55%) was fat mass (FM). At recovery, children treated for SAM had 1.27 kg lower weight, 0.38 kg lower FFM, and 0.90 kg lower FM compared to community controls. However, their fat-free mass index (FFMI) was not different from community controls (Δ0.2 kg/m2; 95% CI -0.1, 0.4). No differences were observed in FFM, FM or fat mass index (FMI) between the study arms at recovery. However, FFMI was 0.35 kg/m2 higher at recovery with the reduced compared to standard dose (p = 0.007) due to slightly lower height (Δ0.22 cm; p = 0.25) and higher FFM (Δ0.11 kg; p = 0.078) in the reduced dose group.
CONCLUSIONS: Almost half of the weight gain during SAM treatment was FFM. Compared to community controls, children recovered from SAM had a lower FM while their height-adjusted FFM was similar. There was no evidence of a differential effect of a reduced RUTF dose on the tissue accretion of treated children when compared to standard treatment.
Copyright © 2020 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Bioelectrical impedance analysis; Body composition; Burkina Faso; Children; Ready-to-use therapeutic food; Severe acute malnutrition

Year:  2020        PMID: 32184026     DOI: 10.1016/j.clnu.2020.02.038

Source DB:  PubMed          Journal:  Clin Nutr        ISSN: 0261-5614            Impact factor:   7.324


  4 in total

1.  Predictors of time to recovery and non-response during outpatient treatment of severe acute malnutrition.

Authors:  Suvi T Kangas; Cécile Salpéteur; Victor Nikièma; Christian Ritz; Henrik Friis; André Briend; Pernille Kaestel
Journal:  PLoS One       Date:  2022-05-31       Impact factor: 3.752

Review 2.  The relationship between wasting and stunting in young children: A systematic review.

Authors:  Susan Thurstans; Natalie Sessions; Carmel Dolan; Kate Sadler; Bernardette Cichon; Sheila Isanaka; Dominique Roberfroid; Heather Stobaugh; Patrick Webb; Tanya Khara
Journal:  Matern Child Nutr       Date:  2021-09-05       Impact factor: 3.092

3.  Soy Protein Alleviates Malnutrition in Weaning Rats by Regulating Gut Microbiota Composition and Serum Metabolites.

Authors:  Zuchen Wei; Nong Zhou; Liang Zou; Zhenxing Shi; Baoqing Dun; Guixing Ren; Yang Yao
Journal:  Front Nutr       Date:  2021-11-29

4.  Economic evaluation of a reduced dosage of ready-to-use therapeutic foods to treat uncomplicated severe acute malnourished children aged 6-59 months in Burkina Faso.

Authors:  Dieynaba S N'Diaye; Bibata Wassonguema; Victor Nikièma; Suvi T Kangas; Cécile Salpéteur
Journal:  Matern Child Nutr       Date:  2021-02-23       Impact factor: 3.092

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.